Literature DB >> 12926044

Matrix-dependent plasticity of the malignant phenotype of bladder cancer cells.

Robert E Hurst1, Kimberly D Kyker, Rebecca B Bonner, Ron D Bowditch, George P Hemstreet.   

Abstract

The purpose of this study was to investigate the effect of cancer- and normal basement membrane-derived extracellular matrix to modulate the phenotype of bladder cancer cell lines. Five lines, varying in malignancy from papilloma to highly undifferentiated and invasive and immortalized human urothelial cells, were grown on two extracellular matrix preparations, Matrigel and SISgel. Matrigel represents matrix remodeled by malignancy while SISgel, obtained from small intestine submucosa (SIS), represents the normal matrix supporting differentiated cell growth. On Matrigel, regardless of the content of growth factors, the invasive lines displayed an invasive phenotype, while the low grade lines grew as papillary structures. In contrast, when the same cells were grown on SISgel, they grew as a layer of cells one to 5 cells thick, failed to invade, and expressed cell-surface E-cadherin. Unlike breast cancer cells, neutralization of beta 1, beta 4 and alpha 6 integrins altered cell-cell and cell-matrix adhesiveness but did not alter the phenotype. When invasive cells were grown on mixtures of SISgel and Matrigel, the phenotype changed gradually, not abruptly, indicating that factors within the gel reversibly alter the phenotypic expression of invasion. In summary, the phenotype of bladder cancer cells growing in tissue-like 3-dimensional culture is highly plastic, and malignant properties such as invasion and papillary growth can be suppressed by the matrix.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926044      PMCID: PMC2561328     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  28 in total

1.  Expression and in vitro regulation of integrins by normal human urothelial cells.

Authors:  J Southgate; W Kennedy; K A Hutton; L K Trejdosiewicz
Journal:  Cell Adhes Commun       Date:  1995-08

2.  Three-dimensional analysis of the substrate-dependent invasive behavior of a human lung tumor cell line with a confocal laser scanning microscope.

Authors:  A R Strohmaier; H Spring; E Spiess
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

3.  Perlecan and basement membrane-chondroitin sulfate proteoglycan (bamacan) are two basement membrane chondroitin/dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix.

Authors:  J R Couchman; R Kapoor; M Sthanam; R R Wu
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

4.  Extracellular matrix penetration by epithelial cells is influenced by quantitative changes in basement membrane components and growth factors.

Authors:  E Stadler; M Dziadek
Journal:  Exp Cell Res       Date:  1996-12-15       Impact factor: 3.905

5.  Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element.

Authors:  R V Iozzo; J Pillarisetti; B Sharma; A D Murdoch; K G Danielson; J Uitto; A Mauviel
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

Review 6.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth.

Authors:  R V Iozzo
Journal:  Crit Rev Biochem Mol Biol       Date:  1997       Impact factor: 8.250

7.  Identification of extractable growth factors from small intestinal submucosa.

Authors:  S L Voytik-Harbin; A O Brightman; M R Kraine; B Waisner; S F Badylak
Journal:  J Cell Biochem       Date:  1997-12-15       Impact factor: 4.429

8.  Beta 4 integrin transfection of UM-UC-2 (human bladder carcinoma) cells: stable expression of a spontaneous cytoplasmic truncation mutant with rapid loss of clones expressing intact beta 4.

Authors:  S Y Kim; N J Bachman; T S Nair; S Goldsmith; M Liebert; H B Grossman; M I Lomax; T E Carey
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

Review 9.  Involvement of integrins in cell survival.

Authors:  R C Bates; L F Lincz; G F Burns
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

10.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.

Authors:  V M Weaver; O W Petersen; F Wang; C A Larabell; P Briand; C Damsky; M J Bissell
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

View more
  18 in total

1.  Template-driven gene selection procedure.

Authors:  N Knowlton; I Dozmorov; K D Kyker; R Saban; C Cadwell; M B Centola; R E Hurst
Journal:  Syst Biol (Stevenage)       Date:  2006-01

Review 2.  Biochemical and biomechanical characterization of porcine small intestinal submucosa (SIS): a mini review.

Authors:  Lei Shi; Vincent Ronfard
Journal:  Int J Burns Trauma       Date:  2013-11-01

3.  Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream.

Authors:  Dianzhong Zhang; Amber E Hudson; Catherine F Delostrinos; Nicole Carmean; Rocky Eastman; Bryson Hicks; Robert E Hurst; James A Bassuk
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 4.  [Tumour-stroma interactions in urothelial cancer].

Authors:  J Hatina; M Kripnerová; J Tuková; J Šrámek; P Dvořák; M Pešta; J Dobrá; V Babuška; J Racek; M Sobol; A Philimonenko; P Hozák; Z Czuba; W A Schulz; C Strell; S Grimm; S Jennek; K-H Friedrich
Journal:  Urologe A       Date:  2015-04       Impact factor: 0.639

5.  Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering.

Authors:  Peter M Crapo; Yadong Wang
Journal:  Acta Biomater       Date:  2009-11-01       Impact factor: 8.947

6.  Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix.

Authors:  Paul J Hauser; Zhiyong Han; Puneet Sindhwani; Robert E Hurst
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

7.  Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype.

Authors:  Lindsey T Saldin; Shil Patel; Li Zhang; Luai Huleihel; George S Hussey; David G Nascari; Lina M Quijano; Xue Li; Divya Raghu; Anant K Bajwa; Nicholas G Smith; Christopher C Chung; Ashten N Omstead; Juliann E Kosovec; Blair A Jobe; Neill J Turner; Ali H Zaidi; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2019-03       Impact factor: 3.845

8.  A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model.

Authors:  Bartley J Gill; Don L Gibbons; Laila C Roudsari; Jennifer E Saik; Zain H Rizvi; Jonathon D Roybal; Jonathan M Kurie; Jennifer L West
Journal:  Cancer Res       Date:  2012-09-04       Impact factor: 12.701

9.  Extracellular matrix heterogeneity regulates three-dimensional morphologies of breast adenocarcinoma cell invasion.

Authors:  Yoojin Shin; Hyunju Kim; Sewoon Han; Jihee Won; Hyo Eun Jeong; Eun-Sook Lee; Roger D Kamm; Jae-Hong Kim; Seok Chung
Journal:  Adv Healthc Mater       Date:  2012-11-26       Impact factor: 9.933

10.  Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy".

Authors:  Robert E Hurst; Paul J Hauser; Kimberly D Kyker; Jonathan E Heinlen; Jason P Hodde; Michael C Hiles; Stanley D Kosanke; Mikhail Dozmorov; Michael A Ihnat
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.